NDC 0002-4184

Evista

Raloxifene Hydrochloride

Evista is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Raloxifene Hydrochloride.

Product ID0002-4184_1a6fc7e9-8d85-44b5-9d5b-b9c352e99142
NDC0002-4184
Product TypeHuman Prescription Drug
Proprietary NameEvista
Generic NameRaloxifene Hydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1998-01-06
Marketing CategoryNDA / NDA
Application NumberNDA020815
Labeler NameEli Lilly and Company
Substance NameRALOXIFENE HYDROCHLORIDE
Active Ingredient Strength60 mg/1
Pharm ClassesEstrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0002-4184-02

100 TABLET in 1 BOTTLE (0002-4184-02)
Marketing Start Date2016-12-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0002-4184-07 [00002418407]

Evista TABLET
Marketing CategoryNDA
Application NumberNDA020815
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-12-16
Marketing End Date2019-11-30

NDC 0002-4184-02 [00002418402]

Evista TABLET
Marketing CategoryNDA
Application NumberNDA020815
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-12-16

NDC 0002-4184-30 [00002418430]

Evista TABLET
Marketing CategoryNDA
Application NumberNDA020815
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-12-16

Drug Details

Active Ingredients

IngredientStrength
RALOXIFENE HYDROCHLORIDE60 mg/1

OpenFDA Data

SPL SET ID:fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1490065
  • 1490067
    • UPC Code
  • 0300024184022

    • Pharmacological Class

    • Estrogen Agonist/Antagonist [EPC]
    • Selective Estrogen Receptor Modulators [MoA]

    NDC Crossover Matching brand name "Evista" or generic name "Raloxifene Hydrochloride"

    NDCBrand NameGeneric Name
    0002-4184EvistaRaloxifene hydrochloride
    0093-7290Raloxifene HydrochlorideRaloxifene Hydrochloride
    0440-5295Raloxifene HydrochlorideRaloxifene Hydrochloride
    0904-6902Raloxifene hydrochlorideRaloxifene hydrochloride
    16714-213Raloxifene HydrochlorideRaloxifene Hydrochloride
    31722-256Raloxifene HydrochlorideRaloxifene Hydrochloride
    42291-726Raloxifene HydrochlorideRaloxifene Hydrochloride
    43353-253Raloxifene HydrochlorideRaloxifene Hydrochloride
    43598-505Raloxifene hydrochlorideRaloxifene hydrochloride
    50090-3363Raloxifene hydrochlorideRaloxifene hydrochloride
    50090-3866Raloxifene HydrochlorideRaloxifene Hydrochloride
    50090-6177Raloxifene hydrochlorideRaloxifene hydrochloride
    50228-306Raloxifene hydrochlorideRaloxifene hydrochloride
    50268-694Raloxifene HydrochlorideRaloxifene Hydrochloride
    52343-137Raloxifene HydrochlorideRaloxifene Hydrochloride
    63629-8209Raloxifene HydrochlorideRaloxifene Hydrochloride
    65162-057Raloxifene HydrochlorideRaloxifene Hydrochloride
    65862-709Raloxifene HydrochlorideRaloxifene Hydrochloride

    Trademark Results [Evista]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EVISTA
    EVISTA
    88240568 5928487 Live/Registered
    Chen Fei
    2018-12-24
    EVISTA
    EVISTA
    75813542 2779811 Dead/Cancelled
    DataInsight, Inc.
    1999-10-04
    EVISTA
    EVISTA
    75396057 not registered Dead/Abandoned
    Exabyte Corporation
    1997-11-25
    EVISTA
    EVISTA
    74488857 2099703 Live/Registered
    Eli Lilly and Company
    1994-02-10
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.